Rakovina Therapeutics Inc(RKV-X)
TSX Venture

Today's Change
Delayed Last Update

Rakovina Therapeutics Inc

999 West Broadway
Suite 720
Vancouver BC V5Z 1K5 CAN
P: 604-619-0225
F: 604-980-6264
https://www.rakovinatherapeutics.com

Sectors & Indices

Sector
Industry
Employees

Profile

Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a greater pace. The company has established a pipeline of distinctive DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Its drug development pipeline consists of candidates like kt-5000AI, kt-2000AI, and kt-3283, targeting solid tumours and PARP-resistant adult and childhood cancers.

Key Executives

NameTitle
David KideckelCFO/Director

More from The Globe

Gildan stock is down, and looking good
Signage is seen at Gildan Activewear Inc.'s annual meeting in Montreal, Tuesday, May 28, 2024. THE CANADIAN PRESS/Christinne Muschi
the mover
Why this money manager is buying Agnico Eagle, Nutrien and trimming Alphabet
Illustration of Martin Pelletier for The Mover, June 19, 2026. Illustration by Joel Kimmel
number cruncher
Top U.S. stocks ranked by Trading Central’s quantitative model
For Number Cruncher column in Globe Investor/ROB only.
Wednesday’s analyst upgrades and downgrades
A Dynamite clothing retail store is shown in Montreal, Friday, Nov. 15, 2024.
number cruncher
Seven Canadian small-cap stocks with cheap valuations
For Number Cruncher column in Globe Investor/ROB only.
Bullish on Freeport-McMoRan Inc.
Monica Rizk
Gildan shares sink 19 per cent on short seller report alleging inflated sales
Gildan Activewear Inc. CEO Glenn Chamandy arrives to speak to the media following the company's annual meeting in Montreal on May 28, 2024.
The highest-yielding stocks on the TSX, plus risk data
The S&P TSX composite index screen at the TMX Market Centre in downtown Toronto is photographed on November 11, 2022.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.